Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.3122
-0.0098 (-3.04%)
At close: Jun 27, 2025, 4:00 PM
0.3000
-0.0122 (-3.91%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Moleculin Biotech Employees
Moleculin Biotech had 17 employees as of December 31, 2024. The number of employees decreased by 1 or -5.56% compared to the previous year.
Employees
17
Change (1Y)
-1
Growth (1Y)
-5.56%
Revenue / Employee
n/a
Profits / Employee
-$1,366,412
Market Cap
4.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
MBRX News
- 2 days ago - Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga
- 8 days ago - Moleculin Announces $5.9 Million Public Offering - GlobeNewsWire
- 10 days ago - Moleculin Participates in Virtual Investor “What This Means” Segment - GlobeNewsWire
- 10 days ago - Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML - GlobeNewsWire
- 23 days ago - Moleculin Releases On-Demand KOL Webcast to Discuss Data from its Phase 1B/2 Study of Annamycin for the Treatment of Soft Tissue Sarcoma (STS) Lung Metastases (MB-107) - GlobeNewsWire
- 24 days ago - Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107) - GlobeNewsWire
- 6 weeks ago - Moleculin Biotech, Inc. (MBRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire